A systematic analysis of influenza vaccine shortage policies

Uscher‐Pines, Lori; Barnett, Daniel J.; Sapsin, Jason W.; Bishai, David; Balicer, Ran D.

doi:10.1016/j.puhe.2007.06.005

Cited by 29 publications

(17 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It may be worthwhile to invest millions of dollars each year to ensure that the vaccine supply chain effectively gets vaccine to older adults on time. [20-22]…”

Section: Discussionmentioning

confidence: 99%

The timing of influenza vaccination for older adults (65 years and older)

Lee

Tai

Bailey

2009

Vaccine

View full text Add to dashboard Cite

While studies have found influenza vaccination to be cost-effective in older adults (65 years or older), they have not looked at how the vaccine's economic value may vary with the timing of vaccine administration. We developed a set of computer simulation models to evaluate the economic impact of vaccinating older adults at different months. Our models delineated the costs and utility losses in delaying vaccination past October and suggest that policy makers and payors may consider structuring incentives (≤ $2.50 per patient) to vaccinate in October. Our results also suggest that vaccination is still cost-effective through the end of February.

show abstract

“…It may be worthwhile to invest millions of dollars each year to ensure that the vaccine supply chain effectively gets vaccine to older adults on time. [20-22]…”

Section: Discussionmentioning

confidence: 99%

The timing of influenza vaccination for older adults (65 years and older)

Lee

Tai

Bailey

2009

Vaccine

View full text Add to dashboard Cite

show abstract

“…This property renders production an undesirably dynamic and open system with a complex logistics between the limited number of facilities that can supply such eggs and those that can process this substrate [61,62]. …”

Section: Finite Cell Culturesmentioning

confidence: 99%

Matrix and Backstage: Cellular Substrates for Viral Vaccines

Jordan¹,

Sandig²

2014

Viruses

View full text Add to dashboard Cite

Vaccines are complex products that are manufactured in highly dynamic processes. Cellular substrates are one critical component that can have an enormous impact on reactogenicity of the final preparation, level of attenuation of a live virus, yield of infectious units or antigens, and cost per vaccine dose. Such parameters contribute to feasibility and affordability of vaccine programs both in industrialized countries and developing regions. This review summarizes the diversity of cellular substrates for propagation of viral vaccines from primary tissue explants and embryonated chicken eggs to designed continuous cell lines of human and avian origin.

show abstract

“…SWOT analysis (Table 4) is a popular framework in management and business and has been applied in planning and evaluating public health programmes and policies (UscherPines, Barnett, Sapsin, Bishai, & Balicer, 2008). In this analysis, programme strengths and weaknesses were identified from the evaluations (especially end-cycle) that were administered to mentors and mentees while the programme opportunities and threats were identified by authors based on their understanding of the external environment in which the MENTOR-VIP programme is implemented (Edwards et al, 1999;Huerta, Balicer, & Leventhal, 2003;Kahveci & Meads, 2008;Mooney, 2002;Uscher-Pines et al, 2008; Wazir, Shaikh, & Ahmed, 2013).…”

Section: Mentor-vip Swot Analysismentioning

confidence: 99%

E-mentoring for violence and injury prevention: Early lessons from a global programme

Wadhwaniya

Meddings

Gururaj

et al. 2015

Global Public Health

View full text Add to dashboard Cite

To address the growing burden of violence and injuries, especially in low- and middle-income countries, in 2007 the World Health Organization launched MENTOR-VIP, a global violence and injury prevention (VIP)-mentoring programme. The programme aims to develop human resource capacity through 12-month mentoring arrangements between individual VIP experts (mentors) and less-experienced injury practitioners (mentees). In this paper, we review the first five years of the programme (2007-2011) using a systems analysis and SWOT (Strengths, Weaknesses, Opportunities and Threats) frameworks, discuss programme findings and make recommendations. A well-defined programme with clear instructions, successful matching of mentorship pairs with similar interests and language, a formal accord agreement, institutional support and effective communication were identified as programme strengths. Overambitious projects, lack of funds and difficulties with communications were identified as programme weaknesses. Mentorship projects that require institutional permissions or resources could be potential threats to the success of mentorship. The study resulted in the four following recommendations to strengthen the programme: (1) institute additional steps in selection and matching mentor-mentee pair; (2) train mentors on e-mentoring; (3) conduct special orientation for mentees to the programme; and (4) maintain effective and open communication throughout the programme.

show abstract

A systematic analysis of influenza vaccine shortage policies

Cited by 29 publications

References 18 publications

The timing of influenza vaccination for older adults (65 years and older)

The timing of influenza vaccination for older adults (65 years and older)

Matrix and Backstage: Cellular Substrates for Viral Vaccines

E-mentoring for violence and injury prevention: Early lessons from a global programme

Contact Info

Product

Resources

About